These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1329768)

  • 1. Inhibition of sodium pump by bepridil. An in vitro and microcalorimetric study.
    Kovacic H; Gallice P; Crevat A
    Biochem Pharmacol; 1992 Oct; 44(8):1529-34. PubMed ID: 1329768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on the role of sodium- and potassium-activated adenosine triphosphatase inhibition in the pathogenesis of human hypertension. Changes in vascular and cardiac function following inhibition of the sodium pump in normotensive subjects and effects of calcium entry blockade.
    Kramer HJ; Glänzer K; Freitag T; Schönfeld J; Sorger M; Schlebusch H; Düsing R; Krück F
    Klin Wochenschr; 1985 Jan; 63(1):32-6. PubMed ID: 2579261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevating intracellular free Mg2+ preserves sensitivity of Na(+)-K+ pump to ATP at reduced temperatures in guinea pig red blood cells.
    Marjanovic M; Willis JS
    J Comp Physiol B; 1995; 165(6):428-32. PubMed ID: 8576455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Verapamil, diltiazem and nifedipine interactions with calmodulin stimulated (Ca2+ + Mg2+)-ATPase.
    Kim HC; Raess BU
    Biochem Pharmacol; 1988 Mar; 37(5):917-20. PubMed ID: 2964236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chloride dependent intracellular pH increase induced by bepridil in human red blood cells: a possible involvement in correction of ischemic acidosis.
    Kovacic H; Gallice P; Sarrazin M; Crevat A
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1509-14. PubMed ID: 8263812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversible inhibition of sodium and potassium-dependent adenosine triphosphatase by the pyridine derivative, AU-1421 during turnover cycle.
    Takada J
    Biochem Pharmacol; 1990 Oct; 40(7):1527-31. PubMed ID: 2171532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the inhibitory effect of ouabain and dihydroouabain on the Na(+)-K+ ATPase from frog skin.
    Nichols JR; Maldonado HS
    Gen Pharmacol; 1993 Mar; 24(2):349-52. PubMed ID: 8387052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of monovalent cations with the sodium pump of low-potassium goat erythrocytes.
    Cavieres JD; Ellory JC
    J Physiol; 1977 Sep; 271(1):289-318. PubMed ID: 144181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of several ligands on the potassium-vanadate interaction in the inhibition of the (Na+ + K+)-ATPase and the Na+, K+ pump.
    Beaugé L; Berberian G
    Biochim Biophys Acta; 1983 Jan; 727(2):336-50. PubMed ID: 6301556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of calcium channel blockers on ouabain-induced oscillatory afterpotentials in organ-cultured young embryonic chick hearts.
    Kojima M; Sperelakis N
    Eur J Pharmacol; 1986 Mar; 122(1):65-73. PubMed ID: 2420619
    [TBL] [Abstract][Full Text] [Related]  

  • 11. External Na dependence of ouabain-sensitive ATP:ADP exchange initiated by photolysis of intracellular caged-ATP in human red cell ghosts.
    Kaplan JH; Hollis RJ
    Nature; 1980 Dec; 288(5791):587-9. PubMed ID: 6255339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of intracellular calcium on the sodium pump of human red cells.
    Brown AM; Lew VL
    J Physiol; 1983 Oct; 343():455-93. PubMed ID: 6315922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacology of calcium antagonists.
    Schwartz A; Matlib MA; Balwierczak J; Lathrop DA
    Am J Cardiol; 1985 Mar; 55(7):3C-7C. PubMed ID: 3872055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calmodulin-stimulated plasma membrane (Ca2+ + Mg2+)-ATPase: inhibition by calcium channel entry blockers.
    Raess BU; Gersten MH
    Biochem Pharmacol; 1987 Aug; 36(15):2455-9. PubMed ID: 3038124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological properties of contraction caused by sodium removal in muscle strips isolated from canine coronary artery.
    Maseki T; Abe T; Tomita T
    Eur J Pharmacol; 1990 Nov; 190(3):355-63. PubMed ID: 2272373
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by vanadium of sodium and potassium dependent adenosinetriphosphatase derived from animal and human tissues.
    Nechay BR; Saunders JP
    J Environ Pathol Toxicol; 1978; 2(2):247-62. PubMed ID: 216760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction of magnesium with the sodium pump of the human red cell.
    Sachs JR
    J Physiol; 1988 Jun; 400():575-91. PubMed ID: 2843641
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of (Na+ + K+)-ATPase in binding and actions of palytoxin on human erythrocytes.
    Böttinger H; Béress L; Habermann E
    Biochim Biophys Acta; 1986 Sep; 861(1):165-76. PubMed ID: 2875735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking of Na+/K+ transport by the MgPO4 complex analogue Co(NH3)4PO4 leaves the Na+/Na(+)-exchange reaction of the sodium pump unaltered and shifts its high-affinity ATP-binding site to a Na(+)-like form.
    Buxbaum E; Schoner W
    Eur J Biochem; 1990 Oct; 193(2):355-60. PubMed ID: 1699757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Palytoxin-induced channel formation within the Na+/K+-ATPase does not require a catalytically active enzyme.
    Scheiner-Bobis G; Schneider H
    Eur J Biochem; 1997 Sep; 248(3):717-23. PubMed ID: 9342222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.